Skip to main content
SpringerLink
Log in

Antimicrobial Therapy

Cost-Benefit Considerations

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Avorn J, Soumcrai SB, Taylor W, Wcsscls MR, Janousck J, et al. Reduction of incorrect antibiotic dosing through a structured educational order form. Archives of Internal Medicine 148: 1720–1724, 1988

    Article  PubMed  CAS  Google Scholar 

  • Barriere SL. Cost containment of antimicrobial therapy. Drug Intelligence and Clinical Pharmacy 19: 271–281, 1985

    Google Scholar 

  • Bell S. Further observations on the value of oral penicillins in chronic staphylococcal osteomyelitis. Medical Journal of Australia 2: 591–593, 1976

    PubMed  CAS  Google Scholar 

  • Black J, Hunt TL, Godley PJ, Matthew E. Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis. Journal of Infectious Diseases 155: 968–972, 1987

    Article  PubMed  CAS  Google Scholar 

  • Briceland LL, Nightingale CH, Quintiliani R, Cooper BW, Smith KS. Antibiotic streamlining from combination therapy to monotherapy using an interdisciplinary approach. Archives of Internal Medicine 148: 2019–2022, 1988

    Article  PubMed  CAS  Google Scholar 

  • Britton HL, Schwinghammer TL, Romano MJ. Cost containment through restriction of cephalosporins. American Journal of Hospital Pharmacy 38: 1897–1900, 1981

    PubMed  CAS  Google Scholar 

  • Brooks GF, Barriere SL. Clinical use of the new beta-lactam drugs: practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees. Annals of Internal Medicine 98: 530–535, 1983

    PubMed  CAS  Google Scholar 

  • Craig WA, Uman SJ, Shaw WR, Ramgopal V, Eagan LL, et al. Hospital use of antimicrobial drugs: survey at 19 hospitals and results of antimicrobial control program. Annals of Internal Medicine 89 (Part 2): 793–795, 1978

    PubMed  CAS  Google Scholar 

  • DeTorres OH, White RE. Effect of aminoglycoside-use restrictions on drug cost. American Journal of Hospital Pharmacy 41: 1137–1139, 1984

    PubMed  CAS  Google Scholar 

  • DeVito JM, John JF. Effect of formulary restriction of cefotaxime usage. Archives of Internal Medicine 145: 1053–1056, 1985

    Article  PubMed  CAS  Google Scholar 

  • Durbin WA, Lapidas B, Goldmann DA. Improved antibiotic usage following introduction of a novel prescription system. Journal of the American Medical Association 246: 1796–1800, 1981

    Article  PubMed  Google Scholar 

  • Dzierba SH, Reilly RT, Caselnova DA,III. Cost savings achieved through cephalosporin use review and restriction. American Journal of Hospital Pharmacy 43: 2194–2197, 1986

    PubMed  CAS  Google Scholar 

  • Echols RM, Kowalsky SF. The use of an antibiotic order form for antibiotic utilization reviews: influence on physician’s prescribing patterns. Journal of Infectious Diseases 150: 803–807, 1984

    Article  PubMed  CAS  Google Scholar 

  • Eisenberg JM, Koffer H, Glock HA, Connell ML, Loss LE, et al. What is the cost of nephrotoxieity associated with aminoglycosides? Annals of Internal Medicine 107: 900–909, 1987

    PubMed  CAS  Google Scholar 

  • Fletcher CV, Giese RM, Rodman JH. Pharmacist interventions to improve prescribing of vancomycin and tobramycin. American Journal of Hospital Pharmacy 43: 2198–2201, 1986

    PubMed  CAS  Google Scholar 

  • Gladen HE. Cost-effective aminoglycoside therapy in surgical patients. American Journal of Medicine 80 (Suppl. 6B): 228–233, 1986

    Article  PubMed  CAS  Google Scholar 

  • Guglielmo BJ, Hohn DC, Koo PJ, Hunt TK, Sweet RL, et al. Antibiotic prophylaxis in surgical procedures: a critical analysis of the literature. Archives of Surgery 118: 943–955, 1983

    Article  PubMed  CAS  Google Scholar 

  • Hayman JN, Sbravati EC. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. American Journal of Hospital Pharmacy 42: 1343–1347, 1985

    PubMed  CAS  Google Scholar 

  • Hendeles L. Need for ‘counter-detailing’ antibiotics. American Journal of Hospital Pharmacy 33: 918–924, 1976

    PubMed  CAS  Google Scholar 

  • Hirschman SZ, Meyers BR, Bradbury K, Mehl B, Gendelman S, et al. Use of antimicrobial agents in a university teaching hospital: Evolution of a comprehensive control program. Archives of Internal Medicine 148: 2001–2007, 1988

    Article  PubMed  CAS  Google Scholar 

  • Inajara MT, Paloma JM, Giraldez J, Idoate AJ, Hualde S. Computer-assisted antimicrobial-use monitoring. American Journal of Hospital Pharmacy 43: 664–670, 1986

    Google Scholar 

  • Jones SR, Pannell J, Barks J, Yanchick VA, Bratton T, et al. The effect of an educational program upon hospital antibiotic use. American Journal of the Medical Sciences 273: 79–85, 1977

    Article  PubMed  CAS  Google Scholar 

  • Knodel LC, Goldspiel BR, Gibbs RS. Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section. Antimicrobial Agents and Chemotherapy 32: 853–857, 1988

    Article  PubMed  CAS  Google Scholar 

  • Kunin CM, Tupasi T, Craig WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Annals of Internal Medicine 79: 555–560, 1973

    PubMed  CAS  Google Scholar 

  • LaTorraca R, Martins R. Surveillance of antibiotic use in a community hospital. Journal of the American/Medical Association 242: 2585–2587, 1979

    Article  CAS  Google Scholar 

  • Levitz RE, Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Annals of Internal Medicine 100: 881–889, 1984

    PubMed  CAS  Google Scholar 

  • McGowan Jr JE, Finland M. Usage of antibiotics in a general hospital: effect of requiring justification. Journal of Infectious Diseases 130: 165–168, 1974

    Article  PubMed  Google Scholar 

  • Moleski RJ, Andriole VT. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Reviews of Infectious Diseases 8: 488–493, 1986

    Article  PubMed  CAS  Google Scholar 

  • Neu HC. The new beta-lactamase stable cephalosporins. Annals of Internal Medicine 97: 408–419, 1982

    PubMed  CAS  Google Scholar 

  • Nickman NA, Blissenbach HF, Herrick JD. Medical committee enforcement of policy limiting postsurgical antibiotic use. American Journal of Hospital Pharmacy 41: 2053–2056, 1984

    PubMed  CAS  Google Scholar 

  • Nightengale J, Chaffee BW, Colvin CL, Alexander MR, Rice T, et al. Retrospective evaluation Of vancomycin use in a university hospital. American Journal of Hospital Pharmacy 44: 1807–1809, 1987

    Google Scholar 

  • Noel MW, Paxinos J. Cephalosporins: use review and cost analysis. American Journal of Hospital Pharmacy 35: 933–935, 1978

    PubMed  CAS  Google Scholar 

  • Norris SM, Mandell GL. Tables of antimicrobial agent pharmacology. In Mandell GL et al. (Eds) Principles and practice of infectious diseases, 2nd ed., John Wiley & Sons, New York, 1985

    Google Scholar 

  • Parish LC, Asper R. Systemic treatment of cutaneous infections: a comparative study of ciprofloxacin and cefotaxime. American Journal of Medicine 82 (Suppl. 4A): 227–229, 1987

    PubMed  CAS  Google Scholar 

  • Parker RH, Fossieck BE. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. Annals of Internal Medicine 93: 832–834, 1980

    PubMed  CAS  Google Scholar 

  • Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 315: 552–558, 1986

    Article  PubMed  CAS  Google Scholar 

  • Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. American Journal of Medicine 82 (Suppl 4A): 391–394, 1987

    PubMed  CAS  Google Scholar 

  • Quintiliani R, Klimek JJ, Nightingale CH. Restriction policies for therapy with combination antibiotics. Journal of Infectious Diseases 153: 645–647, 1986

    Article  PubMed  CAS  Google Scholar 

  • Recco RA, Gladstone JL, Friedman SA, Gerken EH. Antibiotic control in a municipal hospital. Journal of the American Medical Association 241: 2283–2286, 1979

    Article  PubMed  CAS  Google Scholar 

  • Scarafile PD, Campbell BD, Kilroy JE, Matthewson HO. Computer-assisted concurrent antibiotic review in a community hospital. American Journal of Hospital Pharmacy 42: 313–315, 1985

    PubMed  CAS  Google Scholar 

  • Schentag JJ, Wels PB, Reitberg DP, Walczak P, Hawkins Van Tyle J, et al. A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Annals of Surgery 198: 35–40, 1983

    Article  PubMed  CAS  Google Scholar 

  • Schwinghammer TL, Romano MJ, Wing EJ. Cost savings associated with use of gentamicin versus tobramycin. American Journal of Hospital Pharmacy 42: 1745–1749, 1985

    PubMed  CAS  Google Scholar 

  • Seligman SE. Reduction in antibiotic costs by restricting use of an oral cephalosporin. American Journal of Medicine 71: 941–944, 1981

    Article  PubMed  CAS  Google Scholar 

  • Shapiro M, Townsend TR, Rosner B, Kass EH. Use of antimicrobial drugs in general hospitals: patterns of prophylaxis. New England Journal of Medicine 301: 351–355, 1979

    Article  PubMed  CAS  Google Scholar 

  • Smith CR, Ambinder R, Lipsky JJ, Petley BG, Israel E, et al. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. Annals of Internal Medicine 101: 469–477, 1984

    PubMed  CAS  Google Scholar 

  • Sohn CA, Wolter HA, McSweeney GW. Effectiveness of a cephalosporin education program — a pharmacy education program. Drug Intelligence and Clinical Pharmacy 14: 272–277, 1980

    PubMed  CAS  Google Scholar 

  • Tanner DJ, Nazarian MQ. Cost containment associated with decreased parenteral antibiotic administration frequencies. American Journal of Medicine (Suppl.), Symposium on ceftriaxone, a new cephalosporin, pp. 104–111, October 19, 1984

  • Wainer JF, Perkins RL, Cordero L. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. Archives of Internal Medicine 139: 167–169, 1979

    Article  Google Scholar 

  • Weinstein MC, Read JL, Mackay DN, Kresel JJ, Ashley H, et al. Cost effective choice of antimicrobial therapy for serious infections. Journal of General Internal Medicine 1: 351–363, 1986

    Article  PubMed  CAS  Google Scholar 

  • Woodward RS, Medoff G, Smith MD, Gray JL III. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. American Journal of Medicine 83: 817–823, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacy, School of Pharmacy, and Department of Laboratory Medicine, Medicine, and Microbiology and Immunology, University of California, San Francisco, California, 94143-0622, USA

    B. Joseph Guglielmo & Geo. F. Brooks

Authors
  1. B. Joseph Guglielmo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geo. F. Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joseph Guglielmo, B., Brooks, G.F. Antimicrobial Therapy. Drugs 38, 473–480 (1989). https://doi.org/10.2165/00003495-198938040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198938040-00001

Keywords

Search

Navigation